SCHEMBL8185693

SCHEMBL8185693

CC1CCCCC1(OC=O)c1cccs1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
MEN1 O00255 1/20 0.37
PRCP P42785 1/20 0.37
KMT2A Q03164 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
CHRM3 P20309 1/20 0.37
OPRM1 P35372 2/20 0.34
OPRL1 P41146 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8183498 0.79 KCNA3 (0.33)
SCHEMBL6595863 0.73 SLC6A3 (0.50) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL6916553 0.73 CHRM3 (0.48) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL6599116 0.71 SLC6A3 (0.42) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL6597123 0.70 SLC6A2 (0.41) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL4021039 0.70 SLC6A3 (0.36) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL6595795 0.70 SLC6A3 (0.40) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL18462027 0.69 SLC6A3 (0.39) SLC6A3LMNATSHRSLC6A2SLC6A4
SCHEMBL8189527 0.69 LMNA (0.41) LMNATSHRSLC6A2SLC6A4CHRM3
Gacyclidine SCHEMBL4465879 0.69 SIGMAR1 (0.57) SLC6A3SLC6A2SLC6A4MEN1PRCP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6107495-A REACTING SPECIFIED 1-(2- OR 3-THIENYL) CYCLOHEXANES WITH A 1,5-DIHALOPENTANE TO FORM CYCLIC (THIENYLCYCLOHEXYL)AMINES SUCH AS 2-ALKYL-(3-THIENYL)CYCLOHEXYL PIPERIDINE; USE AS INTERMEDIATES TO RADIOACTIVE LABELLED MOLECULES SOCIETE D'EXPANSION SCIENTIFIQUE EXPANSIA (FR) 2000-08-22 US disclosed